Brought to you by 
Mylan nets $2.8bn through follow-on offerings
07 Dec 2007
Executive Summary
Mylan completed two follow-on public offerings, netting about $2.8bn. In the first, the company sold 2.14mm of its 6.5% convertible preferred shares (including the overallotment) at $1k apiece; the shares convert into common in three years at between $58.55 and $71.43 each. The second transaction consisted of the sale of 55.4mm common shares (including partial exercise of the overallotment) at $14 apiece.
Deal Industry
- Pharmaceuticals
-
Pharmaceuticals
- Generic Drugs
Deal Status
- Final
Deal Type
-
Financing
- FOPO
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Mylan nets $2.8bn through follow-on offerings
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice